Uveal Melanoma UK National Guidelines.
The United Kingdom (UK) uveal melanoma guideline development group used an evidence based systematic approach (Scottish Intercollegiate Guidelines Network (SIGN)) to make recommendations in key areas of uncertainty in the field including: the use and effectiveness of new technologies for prognostication, the appropriate pathway for the surveillance of patients following treatment for primary uveal melanoma, the use and effectiveness of new technologies in the treatment of hepatic recurrence and the use of systemic treatments. The guidelines were sent for international peer review and have been accredited by NICE. A summary of key recommendations is presented. The full documents are available on the Melanoma Focus website.
Mount Vernon Cancer Centre, Northwood, Middlesex, UK. Electronic address: nathan.pd@gmail.com.
P
P
Nathan
Ocular Oncology Service, St Bartholomew's and Moorfields Eye Hospital, London, UK.
V
V
Cohen
Department Molecular and Clinical Cancer Medicine, University of Liverpool, UK.
S
S
Coupland
OcuMel UK, UK.
K
K
Curtis
Royal Liverpool University Hospital, Liverpool, UK.
B
B
Damato
Royal Liverpool University Hospital, Liverpool, UK.
J
J
Evans
University Hospital Aintree, Liverpool, UK.
S
S
Fenwick
Patient Representative, UK.
L
L
Kirkpatrick
Moorfields Eye Hospital, London, UK.
O
O
Li
The Clatterbridge Cancer Centre, NHS Foundation Trust, Liverpool, UK.
E
E
Marshall
OcuMel UK, UK.
K
K
McGuirk
Southampton University Hospitals and University of Southampton, UK.
C
C
Ottensmeier
University Hospital Southampton, Southampton, UK.
N
N
Pearce
Royal Hallamshire Hospital, Sheffield, UK.
S
S
Salvi
Southampton University Hospitals, NHS Trust, Southampton, UK.
B
B
Stedman
St Bartholomew's Hospital, UK; Barts Cancer Institute, Queen Mary University of London, London, UK.
P
P
Szlosarek
Project Manager, London, UK.
N
N
Turnbull
D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary / Q000628:therapy; D008495:Medical Oncology / Q000592:standards*; D008545:Melanoma / Q000175:diagnosis* / Q000556:secondary / Q000628:therapy*; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D013997:Time Factors; D016896:Treatment Outcome; D014604:Uveal Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D000098943:Uveal Melanoma
Choroidal; Guidelines; Melanoma; UK; Uveal